Everyone over the age of 65 years should wear a smartwatch : Pro and contra

Atrial fibrillation (AF) is one of the most common cardiac arrhythmias and has far-reaching consequences not only for patients, but also for our healthcare system. The prevalence of this condition is expected to double in the coming decades. On the one hand, this is due to our aging population, the...

Full description

Saved in:
Bibliographic Details
Published in:Herzschrittmachertherapie & Elektrophysiologie 2024-12, Vol.35 (4), p.290
Main Authors: Johnson, V, Eckardt, L
Format: Article
Language:ger
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 4
container_start_page 290
container_title Herzschrittmachertherapie & Elektrophysiologie
container_volume 35
creator Johnson, V
Eckardt, L
description Atrial fibrillation (AF) is one of the most common cardiac arrhythmias and has far-reaching consequences not only for patients, but also for our healthcare system. The prevalence of this condition is expected to double in the coming decades. On the one hand, this is due to our aging population, the increasing number of comorbidities, and the improved technical possibilities for detection. A major complication of AF is stroke, whereby at-risk patients can be protected by oral anticoagulation if AF is diagnosed. The extent to which continuous screening for AF in patients with an increased risk of thromboembolic events should be carried out using wearables remains an important point in the current debate.
doi_str_mv 10.1007/s00399-024-01058-2
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3132612938</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3132612938</sourcerecordid><originalsourceid>FETCH-LOGICAL-p566-1f9e2a776df6fe5b167eb4fcde8c964ea2aa46dc1fd962f781772947453a50ce3</originalsourceid><addsrcrecordid>eNpNkM1KAzEcxIMoVqsv4EFy9BLNdzbepNQPKOih9yVN_rGV7aYmu5a-jc_ik7liBU8zAz-GYRC6YPSaUWpuCqXCWkK5JJRRVRF-gE6YFIowJeXhPz9Cp6W80R-esmM0ElZVSlJ9gmbTD8i71AJOg8HdErB7HULEWn197sDlgssy9U3A2yFgh8va5W7rOr_Et_glJ-zagH1qu-zO0FF0TYHzvY7R_H46nzyS2fPD0-RuRjZKa8KiBe6M0SHqCGrBtIGFjD5A5a2W4LhzUgfPYrCaR1MxY7iVRirhFPUgxujqt3aT03sPpavXq-KhaVwLqS-1YIJrxq2oBvRyj_aLNYR6k1fD_F39d4D4BjsaXUQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3132612938</pqid></control><display><type>article</type><title>Everyone over the age of 65 years should wear a smartwatch : Pro and contra</title><source>Springer Link</source><creator>Johnson, V ; Eckardt, L</creator><creatorcontrib>Johnson, V ; Eckardt, L</creatorcontrib><description>Atrial fibrillation (AF) is one of the most common cardiac arrhythmias and has far-reaching consequences not only for patients, but also for our healthcare system. The prevalence of this condition is expected to double in the coming decades. On the one hand, this is due to our aging population, the increasing number of comorbidities, and the improved technical possibilities for detection. A major complication of AF is stroke, whereby at-risk patients can be protected by oral anticoagulation if AF is diagnosed. The extent to which continuous screening for AF in patients with an increased risk of thromboembolic events should be carried out using wearables remains an important point in the current debate.</description><identifier>ISSN: 1435-1544</identifier><identifier>EISSN: 1435-1544</identifier><identifier>DOI: 10.1007/s00399-024-01058-2</identifier><identifier>PMID: 39585406</identifier><language>ger</language><publisher>Germany</publisher><ispartof>Herzschrittmachertherapie &amp; Elektrophysiologie, 2024-12, Vol.35 (4), p.290</ispartof><rights>2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39585406$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Johnson, V</creatorcontrib><creatorcontrib>Eckardt, L</creatorcontrib><title>Everyone over the age of 65 years should wear a smartwatch : Pro and contra</title><title>Herzschrittmachertherapie &amp; Elektrophysiologie</title><addtitle>Herzschrittmacherther Elektrophysiol</addtitle><description>Atrial fibrillation (AF) is one of the most common cardiac arrhythmias and has far-reaching consequences not only for patients, but also for our healthcare system. The prevalence of this condition is expected to double in the coming decades. On the one hand, this is due to our aging population, the increasing number of comorbidities, and the improved technical possibilities for detection. A major complication of AF is stroke, whereby at-risk patients can be protected by oral anticoagulation if AF is diagnosed. The extent to which continuous screening for AF in patients with an increased risk of thromboembolic events should be carried out using wearables remains an important point in the current debate.</description><issn>1435-1544</issn><issn>1435-1544</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNkM1KAzEcxIMoVqsv4EFy9BLNdzbepNQPKOih9yVN_rGV7aYmu5a-jc_ik7liBU8zAz-GYRC6YPSaUWpuCqXCWkK5JJRRVRF-gE6YFIowJeXhPz9Cp6W80R-esmM0ElZVSlJ9gmbTD8i71AJOg8HdErB7HULEWn197sDlgssy9U3A2yFgh8va5W7rOr_Et_glJ-zagH1qu-zO0FF0TYHzvY7R_H46nzyS2fPD0-RuRjZKa8KiBe6M0SHqCGrBtIGFjD5A5a2W4LhzUgfPYrCaR1MxY7iVRirhFPUgxujqt3aT03sPpavXq-KhaVwLqS-1YIJrxq2oBvRyj_aLNYR6k1fD_F39d4D4BjsaXUQ</recordid><startdate>20241201</startdate><enddate>20241201</enddate><creator>Johnson, V</creator><creator>Eckardt, L</creator><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20241201</creationdate><title>Everyone over the age of 65 years should wear a smartwatch : Pro and contra</title><author>Johnson, V ; Eckardt, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p566-1f9e2a776df6fe5b167eb4fcde8c964ea2aa46dc1fd962f781772947453a50ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Johnson, V</creatorcontrib><creatorcontrib>Eckardt, L</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Herzschrittmachertherapie &amp; Elektrophysiologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Johnson, V</au><au>Eckardt, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Everyone over the age of 65 years should wear a smartwatch : Pro and contra</atitle><jtitle>Herzschrittmachertherapie &amp; Elektrophysiologie</jtitle><addtitle>Herzschrittmacherther Elektrophysiol</addtitle><date>2024-12-01</date><risdate>2024</risdate><volume>35</volume><issue>4</issue><spage>290</spage><pages>290-</pages><issn>1435-1544</issn><eissn>1435-1544</eissn><abstract>Atrial fibrillation (AF) is one of the most common cardiac arrhythmias and has far-reaching consequences not only for patients, but also for our healthcare system. The prevalence of this condition is expected to double in the coming decades. On the one hand, this is due to our aging population, the increasing number of comorbidities, and the improved technical possibilities for detection. A major complication of AF is stroke, whereby at-risk patients can be protected by oral anticoagulation if AF is diagnosed. The extent to which continuous screening for AF in patients with an increased risk of thromboembolic events should be carried out using wearables remains an important point in the current debate.</abstract><cop>Germany</cop><pmid>39585406</pmid><doi>10.1007/s00399-024-01058-2</doi></addata></record>
fulltext fulltext
identifier ISSN: 1435-1544
ispartof Herzschrittmachertherapie & Elektrophysiologie, 2024-12, Vol.35 (4), p.290
issn 1435-1544
1435-1544
language ger
recordid cdi_proquest_miscellaneous_3132612938
source Springer Link
title Everyone over the age of 65 years should wear a smartwatch : Pro and contra
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T23%3A44%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Everyone%20over%20the%20age%20of%2065%C2%A0years%20should%20wear%20a%20smartwatch%20:%20Pro%20and%20contra&rft.jtitle=Herzschrittmachertherapie%20&%20Elektrophysiologie&rft.au=Johnson,%20V&rft.date=2024-12-01&rft.volume=35&rft.issue=4&rft.spage=290&rft.pages=290-&rft.issn=1435-1544&rft.eissn=1435-1544&rft_id=info:doi/10.1007/s00399-024-01058-2&rft_dat=%3Cproquest_pubme%3E3132612938%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p566-1f9e2a776df6fe5b167eb4fcde8c964ea2aa46dc1fd962f781772947453a50ce3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3132612938&rft_id=info:pmid/39585406&rfr_iscdi=true